Expert Pushes for Zika, Microcephaly Surveillance

Article

Rapid testing for the Zika virus is a critical need in the recent Ebola-affected countries of Liberia, Sierra Leone and Guinea, says a Georgetown University professor, because of the recent Zika outbreak on nearby Cape Verde and the similarity in symptoms between Zika and early Ebola.

Daniel Lucey

Rapid testing for the Zika virus is a critical need in the recent Ebola-affected countries of Liberia, Sierra Leone and Guinea, says a Georgetown University professor, because of the recent Zika outbreak on nearby Cape Verde and the similarity in symptoms between Zika and early Ebola.

In his Health Security commentary published online today, infectious disease specialist Daniel Lucey, MD, MPH, urges both surveillance for Zika and prospective studies to monitor for microcephaly and other neurologic disorders in West Africa, citing the close travel links with Cape Verde.

“The clinical presentation of ZIKV [Zika virus] infection, although extremely mild compared with typical Ebola virus disease, could cause initial confusion clinically because both can have fever, muscle and joint pain, red eyes, and rash,” writes Lucey. “If a patient with ZIKV infection were to raise initial concern about a potential Ebola virus infection, then a cascade of unnecessary medical, public health, societal, and political issues could be triggered.”

In February 2016, a World Health Organization risk assessment of the Zika virus in Africa placed Liberia, Sierra Leone and Guinea in either a high or moderate risk category. Lucey points out that critical information learned about Zika in the brief time since the report was issued warrants a change.

He proposes three additions: “(1) an explicit strong recommendation for prospective epidemiologic studies to monitor for microcephaly following every known ZIKV outbreak…. ; (2) explicit discussion of the potential confusion in initial differentiation of the clinical presentations of ZIKV infection and (mild) Ebola virus disease; and (3) making available rapid PCR testing for ZIKV as soon as possible in 2016, especially in Guinea, Sierra Leone, and Liberia, as well as Guinea-Bissau.”

Lucey, an adjunct professor of medicine at Georgetown University School of Medicine and senior scholar with the O’Neill Institute for National and Global Health Law, spent several months in West Africa treating patients with Ebola in 2014.

“Bearing witness to the suffering caused by Ebola has led me to call for early action now for Zika and microcephaly in West Africa, as well as action against the panepidemic in the Americas,” Lucey says.

Source: Georgetown University Medical Center 

Related Videos
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Photo of a model operating room. (Photo courtesy of Indigo-Clean and Kenall Manufacturing)
GIANTmicrobes at the 2023 APIC Annual Conference and Exhibition.  (Photo by the author)
Related Content